HALO logo
halo search icon
Kyntra Bio, Inc.

US$6.94

Price Change Indicator
-0.01 (-0.144%)
Kyntra Bio, Inc.
KYNB · NAS

Kyntra Bio, Inc.

Start Trading KYNB for Free

US$6.94

Price Arrow-0.01 (-0.144%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Kyntra Bio, Inc. Overview

KYNB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About KYNB

icon
icon

Telephone

1.415.978.1200

icon

Address

Suite 100, No.6009, 350 Bay Street, San Francisco, CA 94133

Description

Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

KYNB Price Chart

Key Stats

Market Cap

US$28.13M

PE

0.20

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.85 - 12.6

Trade Value (12mth)

US$77,356.00

1 week

1.91%

1 month

-3.34%

YTD

-24.13%

1 year

-15.37%

All time high

1713.75

Key Fundamentals

EPS 3 yr Growth

-157.80%

EBITDA Margin

-692.50%

Operating Cashflow

-$5m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-5.10

Quick Ratio

3.30

Other Data

Shares Outstanding (Fully Diluted)

4m

HALO Sector

Healthcare

Next Company Report Date

01-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

KYNB Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
12 May 26
12 May 26
12 May 26

KYNB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-73.03-11.8945.36locklocklock
EPS (Fully Diluted)
 $locklocklocklock-73.03-11.8945.36locklocklock
Growth
 %locklocklocklock6.983.7481.5locklocklock
PE
 XlocklocklocklockN/AN/A0.2locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Kyntra Bio, Inc. (KYNB:NAS)?
Halo FAQ
The current share price of Kyntra Bio, Inc. (KYNB:NAS) is USD$6.94.
What is the 52-week high share price for Kyntra Bio, Inc. (KYNB:NAS)?
Halo FAQ
The 52-week high share price for Kyntra Bio, Inc. (KYNB:NAS) is USD$12.60.
What is the 52-week low share price for Kyntra Bio, Inc. (KYNB:NAS)?
Halo FAQ
The 52-week low share price for Kyntra Bio, Inc. (KYNB:NAS) is USD$4.85.
What is the dividend yield for Kyntra Bio, Inc. (KYNB:NAS)?
Halo FAQ
Kyntra Bio, Inc. (KYNB:NAS) does not pay a dividend.
What was Kyntra Bio, Inc. (KYNB:NAS) last dividend payment?
Halo FAQ
Kyntra Bio, Inc. (KYNB:NAS) does not pay a dividend.
What is the franking level for Kyntra Bio, Inc. (KYNB:NAS)?
Halo FAQ
Kyntra Bio, Inc. (KYNB:NAS) has a franking level of 0.00%.
In which sector is Kyntra Bio, Inc. (KYNB:NAS) classified?
Halo FAQ
Kyntra Bio, Inc. (KYNB:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Kyntra Bio, Inc. (KYNB:NAS)?
Halo FAQ
The current P/E ratio for Kyntra Bio, Inc. (KYNB:NAS) is 0.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial